Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-0807

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-0807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)

A line chart depicting the percent maintained over six months for Esomeprazole Magnesium at doses of 40 mg, 20 mg, 10 mg, and a placebo. The y-axis shows percent maintained from 0 to 100, and the x-axis represents time in months with scheduled visits indicated. Four lines show comparative data trends for each dose and placebo group.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)

A line graph depicting the percentage maintained over a 6-month period with scheduled visits noted. The graph compares Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses against a placebo. The y-axis represents the percent maintained from 0 to 100%. The 40 mg and 20 mg doses show high maintenance percentages near 100%, while the 10 mg dose shows moderate maintenance around 70-80%, and placebo declines sharply to about 30%.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium Delayed-Release Capsules at 20 mg and 40 mg doses compared to placebo. The y-axis represents the percent symptom-free, ranging from 0 to 100%, and the x-axis represents diary days from 0 to 28. The graph illustrates higher symptom-free percentages for both Esomeprazole doses compared to placebo throughout the period.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium delayed-release capsules at 20 mg and 40 mg strengths compared to placebo. The x-axis represents diary days 0 to 28, and the y-axis represents the percent of patients symptom-free from 0 to 100%. Three lines depict symptom-free percentages for 20 mg, 40 mg, and placebo groups over time.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure of esomeprazole magnesium with associated magnesium ions and water molecules, showing molecular composition relevant to the active ingredient in Esomeprazole Magnesium capsules.*

FDA Label Image

Label Image (Lbl713350807)

Label for Esomeprazole Magnesium DR 20 mg capsule by Bryant Ranch Prepack. The label compares to Nexium 20 mg capsule by Aurobindo Pharma USA Inc. It states the capsule is white, lot number 1523487, and includes storage instructions to keep at 20°-25°C (68°-77°F) and out of reach of children. The NDC on the label is 71335-0807-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.